Skip to main content
TipRanks
Go Ultimate75% OFF

Jeremy Levin Insider Profile

11 Followers

Jeremy Levin, EC, Director at Ovid Therapeutics, holds 3.77M shares in Ovid Therapeutics (Ticker: OVID), holds 43.69K shares in Bristol-Myers Squibb (Ticker: BMY).

Jeremy Levin's Trading History

OVID
Ovid Therapeutics
Mar 25, 2026EC, DirectorUninformative Buy66.27K$9.58M
BMY
Bristol-Myers Squibb
Oct 04, 2011SVP Strat TransactionsUninformative Buy147.61K$2.77M

You May Also Like

Jeremy Levin insider profile FAQ

What is the percentage of profitable transactions made by Jeremy Levin?
The percentage of profitable transactions made by Jeremy Levin is 50%.
What is the average return per transaction made by Jeremy Levin?
The average return per transaction made by Jeremy Levin is 26.00%.
What stocks does Jeremy Levin hold?
Jeremy Levin holds: OVID, BMY stocks.
What was Jeremy Levin’s latest transaction?
Jeremy Levin’s latest transaction was an Uninformative Buy of $66.27K.
What was Jeremy Levin's most profitable transaction?
Jeremy Levin’s most profitable transaction was an Informative Buy of OVID stock on October 10, 2019. The return on the trade was 165.20%.
What is Jeremy Levin's role in Ovid Therapeutics?
Jeremy Levin's role in Ovid Therapeutics is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.